A young patient presented with HTN and VMA 14 mg/24, the causes is/are -a) Medullary carcinoma thyroidb) Von Hippel Lindau syndromec) Graves diseased) Pseudohypoparathyroidisme) Sturge weber syndrome
**Core Concept:** Hypertension (HTN) and Von Hippel-Lindau (VHL) syndrome are both conditions that involve the regulation of blood pressure and the role of the kidneys in maintaining fluid balance. In VHL syndrome, the renal medulla, specifically the collecting ducts, are affected, leading to hypertension and increased urine vanillylmandelic acid (VMA) concentration.
**Why the Correct Answer is Right:** The correct answer is B) Von Hippel-Lindau syndrome because it specifically targets the renal medulla, causing hypertension (HTN) and elevated VMA levels. VHL syndrome is an autosomal dominant disorder with a characteristic triad involving hemangiomas, cysts, and malignancies, particularly in the kidneys, retina, and central nervous system. The affected renal medulla results in increased VMA levels, which is the correct answer.
**Why Each Wrong Option is Incorrect:**
A) Medullary carcinoma thyroid (MCT) is a rare cancer that originates in the parafollicular cells of the thyroid gland, not the kidneys. It is unrelated to hypertension or elevated VMA levels.
C) Graves' disease is an autoimmune thyroid disorder characterized by hyperthyroidism, causing weight loss, goiter, and hypermetabolic state. It is unrelated to hypertension or increased VMA levels in urine.
D) Pseudohypoparathyroidism (PHPT) is a rare condition caused by parathyroid hormone resistance, leading to low calcium levels and hypercalciuria. It is not associated with hypertension or elevated VMA levels.
**Clinical Pearl:** VHL syndrome is a genetic disorder that affects the renal medulla, leading to hypertension and increased VMA levels. This understanding helps differentiate it from other causes of hypertension and elevated VMA levels, such as thyroid disorders, renal artery stenosis, or parathyroid disorders. Early diagnosis and management of VHL syndrome are critical for preventing life-threatening complications and improving patient outcomes.